QL
APGE icon

Quarry LP’s Apogee Therapeutics APGE Stock Holding History

Quarry LP’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,500
Closed -$189K – 1423
2025
Q4 		$189K Buy
+2,500
New +$157K 0.03% 282
2025
Q3 		– Sell
-1,930
Closed -$83.8K – 2166
2025
Q2 		$83.8K Buy
+1,930
New +$73.4K 0.02% 634

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Quarry LP's APGE Position: Q1 2026 in Review

Quarry LP sold out of Apogee Therapeutics (APGE) in Q1 2026, closing a stake of 2,500 shares — an estimated $189K sold.

Quarry LP first reported a position in APGE in Q2 2025 and held it in 2 quarters. The position peaked at $189K in Q4 2025. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Quarry LP reported no remaining Apogee Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 2,500 Apogee Therapeutics shares in Q1 2026, an estimated $189K.
  • Quarry LP first reported a position in Apogee Therapeutics in Q2 2025 and held it in 2 quarters.
  • Quarry LP's Apogee Therapeutics position peaked at $189K in Q4 2025.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.